Madalena association
Alternative Names: Madalena association coated tabletLatest Information Update: 21 Dec 2020
At a glance
- Originator EMS
- Class Antihyperglycaemics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Type 2 diabetes mellitus
Most Recent Events
- 17 Dec 2020 Preclinical trials in Type 2 diabetes mellitus in Brazil (PO) prior to December 2020 (EMS website, December 2020)
- 17 Dec 2020 EMS plans a phase III trial for Type 2 diabetes mellitus (PO, Tablet) in November 2021 (NCT04670666)